|
Showing 1 - 2 of
2 matches in All Departments
Managing the Drug Discovery Process, Second Edition thoroughly
examines the current state of pharmaceutical research and
development by providing experienced perspectives on biomedical
research, drug hunting and innovation, including the requisite
educational paths that enable students to chart a career path in
this field. The book also considers the interplay of stakeholders,
consumers, and drug firms with respect to a myriad of factors.
Since drug research can be a high-risk, high-payoff industry, it is
important to students and researchers to understand how to
effectively and strategically manage both their careers and the
drug discovery process. This new edition takes a closer look at the
challenges and opportunities for new medicines and examines not
only the current research milieu that will deliver novel therapies,
but also how the latest discoveries can be deployed to ensure a
robust healthcare and pharmacoeconomic future. All chapters have
been revised and expanded with new discussions on remarkable
advances including CRISPR and the latest gene therapies, RNA-based
technologies being deployed as vaccines as well as therapeutics,
checkpoint inhibitors and CAR-T approaches that cure cancer,
diagnostics and medical devices, entrepreneurship, and AI. Written
in an engaging manner and including memorable insights, this book
is aimed at anyone interested in helping to save countless more
lives through science. A valuable and compelling resource, this is
a must-read for all students, educators, practitioners, and
researchers at large-indeed, anyone who touches this critical
sphere of global impact-in and around academia and the
biotechnology/pharmaceutical industry.
Managing the Drug Discovery Process: How to Make It More Efficient
and Cost-Effective thoroughly examines the current state of
pharmaceutical research and development by providing
chemistry-based perspectives on biomedical research, drug hunting
and innovation. The book also considers the interplay of
stakeholders, consumers, and the drug firm with attendant factors,
including those that are technical, legal, economic, demographic,
political, social, ecological, and infrastructural. Since drug
research can be a high-risk, high-payoff industry, it is important
to researchers to effectively and strategically manage the drug
discovery process. This book takes a closer look at increasing
pre-approval costs for new drugs and examines not only why these
increases occur, but also how they can be overcome to ensure a
robust pharmacoeconomic future. Written in an engaging manner and
including memorable insights, this book is aimed at redirecting the
drug discovery process to make it more efficient and cost-effective
in order to achieve the goal of saving countless more lives through
science. A valuable and compelling resource, this is a must-read
for all students and researchers in academia and the pharmaceutical
industry.
|
|